Ottobock is at the forefront of revolutionizing mobility and independence for individuals with physical limitations. Founded in 1919, the company has consistently driven innovation in orthopaedic technology, transforming the lives of millions worldwide. Through groundbreaking advancements, Ottobock develops and manufactures high-quality, technologically advanced prosthetics, orthotics, wheelchairs, and exoskeletons. The company's commitment to research and development is evident in its portfolio of pioneering products, such as the C-Leg, the world's first microprocessor-controlled knee joint, and the computer-controlled C-Brace leg orthosis. These innovations empower users to regain movement, participate more fully in daily life, and achieve a greater sense of freedom and independence. Ottobock's dedication extends beyond product development to encompass comprehensive patient care, with a global network of over 400 patient care centres providing customized solutions and support.
As a 'Human Empowerment Company,' Ottobock's core mission is to enhance the quality of life for its users. This philosophy is deeply embedded in its corporate culture and drives its continuous pursuit of technological breakthroughs. The company actively invests in digital transformation, incorporating smart sensors, artificial intelligence, and advanced manufacturing techniques into its processes and products. This forward-thinking approach ensures that Ottobock remains a leader in wearable human bionics, constantly pushing the boundaries of what's possible in medical technology. Furthermore, Ottobock demonstrates a strong commitment to social responsibility, notably through its long-standing partnership with the Paralympic Games, providing technical service to athletes since 1988. This dedication to empowering individuals and advancing the field of orthopaedic technology solidifies Ottobock's position as an innovator and a global leader in its industry.
United States only
Germany
